Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer
- 1 July 2002
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 181 (1) , 1-9
- https://doi.org/10.1016/s0304-3835(01)00795-9
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-κBCytokine & Growth Factor Reviews, 2001
- Involvement of the NF‐κB pathway in the transforming properties of the TEL–Jak2 leukemogenic fusion proteinFEBS Letters, 2001
- The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphomaBritish Journal of Haematology, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofenOncogene, 1999
- The Rel/NF-κB signal transduction pathway: introductionOncogene, 1999
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Bcl-3-mediated nuclear regulation of the NF-кB trans-activating factorImmunology Today, 1994
- B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50Cell, 1991